After several years of restructuring, Switzerland-based Clariant is looking to develop its second-generation bioethanol technology – which uses crops to create biofuel – as a direct result of its $2.5 billion buyout of Sued-Chemie. The company, purchased in 2011, focuses on catalyst making and has reportedly allowed for Clariant to utilize more advanced technology and research. The company has now announced new testing of that technology in efforts to strengthen its stance against rivals Royal DSM NV and Novosymes A/S. Testing is reportedly going on in Munich, Germany. The company is also planning to sell three of its commodity-chemical units for $1.3 billion to re-invest profits into the project. Clariant says the deals will be finalized by the end of this September.
Featured News
Justice Department Backs xAI in Environmental Lawsuit Over Mississippi Data Center
Jun 16, 2026 by
CPI
National Security Concerns Are Shaping AI Infrastructure Development
Jun 16, 2026 by
CPI
Colorado Refines, Rather Than Retreats From, AI Regulation
Jun 16, 2026 by
CPI
Canada Opens Broad Antitrust Investigation Into Food Supply Chain Amid Cost Concerns
Jun 16, 2026 by
CPI
Ballard Spahr Strengthens Antitrust Bench as Competition Work Intensifies
Jun 16, 2026 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – (Geo)Political Antitrust
May 28, 2026 by
CPI
Competition Policy in Turbulent Geopolitical Times
May 28, 2026 by
Christophe Carugati & Annabelle Gawer
The New Political Determinants of U.S. Antitrust Policy
May 28, 2026 by
Aziz Z. Huq
The Geopolitical Rewiring of Antitrust
May 28, 2026 by
Hayane C. Dahmen
Three Strikes Against Political Antitrust
May 28, 2026 by
Nolan McCarty & Sepehr Shahshahani